Metabolic regulation of innate lymphoid cell-mediated tissue protection-linking the nutritional state to barrier immunity

Frontiers in Immunology

Volumn 8, Issue DEC, 2017, Pages

  Wilhelm, Christoph ^a   Masouleh, Schekufe Kharabi ^a   Kazakov, Alexander ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Allergic inflammation; Aryl hydrocarbon receptor; Immunometabolism; Innate lymphoid cells; Lipid mediators; Metabolic syndrome; Vitamin A

Indexed keywords

ARACHIDONIC ACID; ARGINASE 1; AROMATIC HYDROCARBON RECEPTOR; CHEMOKINE RECEPTOR CCR9; FORMYLPEPTIDE RECEPTOR LIKE 1; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 22; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; LEUKOTRIENE D4; LIGAND; MAMMALIAN TARGET OF RAPAMYCIN; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; RETINOL; UNCOUPLING PROTEIN 1;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL INFECTION; CELL PROLIFERATION; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTRAPERITONEAL FAT; LIPOLYSIS; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MACROPHAGE ACTIVATION; MEDIATOR; METABOLIC REGULATION; METABOLIC STRESS; METABOLIC SYNDROME X; NATURAL KILLER CELL; NONHUMAN; NUTRIENT AVAILABILITY; NUTRITIONAL STATUS; OXIDATIVE PHOSPHORYLATION; RETINOL DEFICIENCY;

EID: 85037633435     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01742     Document Type: Article

References (72)

1. Artis D, Spits H. The biology of innate lymphoid cells. Nature (2015) 517:293-301. doi:10.1038/nature14189
2. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol (2013) 13:145-9. doi:10.1038/nri3365
3. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity (2013) 38:769-81. doi:10.1016/j.immuni.2013.02.010
4. Klose CSN, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell (2014) 157:340-56. doi:10.1016/j.cell.2014.03.030
5. Licona-Limón P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol (2013) 14:536-42. doi:10.1038/ni.2617
6. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, et al. Innate lymphoid cells drive IL-23 dependent innate intestinal pathology. Nature (2010) 464:1371-5. doi:10.1038/nature08949
7. Geremia A, Arancibia-Cárcamo CV, Fleming MPP, Rust N, Singh B, Mortensen NJ, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 208:1127-33. doi:10.1084/jem.20101712
8. Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature (2015) 519:242-6. doi:10.1038/nature14115
9. Lee M-W, Odegaard JI, Mukundan L, Qiu Y, Molofsky AB, Nussbaum JC, et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell (2014) 160:74-87. doi:10.1016/j.cell.2014.12.011
10. Hams E, Locksley RM, McKenzie ANJ, Fallon PG. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J Immunol (2013) 191:5349-53. doi:10.4049/jimmunol.1301176
11. Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya M, et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol (2012) 13:144-51. doi:10.1038/ni.2187
12. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science (2011) 334:1561-5. doi:10.1126/science.1214914
13. Qiu J, Heller JJ, Guo X, Chen ZM, Fish K, Fu YX, et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity (2012) 36:92-104. doi:10.1016/j.immuni.2011.11.011
14. Mielke LA, Jones SA, Raverdeau M, Higgs R, Stefanska A, Groom JR, et al. Retinoic acid expression associates with enhanced IL-22 production by gammadelta T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med (2013) 210:1117-24. doi:10.1084/jem.20121588
15. Spencer SP, Wilhelm C, Yang Q, Hall JA, Bouladoux N, Boyd A, et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 343:432-7. doi:10.1126/science.1247606
16. van de Pavert SA, Ferreira M, Domingues RG, Ribeiro H, Molenaar R, Moreira-Santos L, et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature (2014) 508:123-7. doi:10.1038/nature13158
17. Monticelli LA, Buck MD, Flamar AL, Saenz SA, Tait Wojno ED, Yudanin NA, et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol (2016) 17:656-65. doi:10.1038/ni.3421
18. Wilhelm C, Harrison OJ, Schmitt V, Pelletier M, Spencer SP, Urban JF Jr, et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J Exp Med (2016) 213:1409-18. doi:10.1084/jem.20151448
19. Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol (2012) 12:696-708. doi:10.1038/nri3299
20. Harrison EH. Mechanisms of digestion and absorption of dietary vitamin A. Annu Rev Nutr (2005) 25:87-103. doi:10.1146/annurev.nutr.25.050304.092614
21. Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity (2011) 35:13-22. doi:10.1016/j.immuni.2011.07.002
22. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell (2008) 134:921-31. doi:10.1016/j.cell.2008.09.002
23. Liu Z-M, Wang K-P, Ma J, Guo Zheng S. The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell Mol Immunol (2015) 12:553-7. doi:10.1038/cmi.2014.133
24. Goverse G, Labao-Almeida C, Ferreira M, Molenaar R, Wahlen S, Konijn T, et al. Vitamin A controls the presence of RORγ+ innate lymphoid cells and lymphoid tissue in the small intestine. J Immunol (2016) 196:5148-55. doi:10.4049/jimmunol.1501106
25. Kim MH, Taparowsky EJ, Kim CH. Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity (2015) 43:107-19. doi:10.1016/j.immuni.2015.06.009
26. Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, et al. Interleukin-12 and -23 control plasticity of Cd127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity (2015) 43:146-60. doi:10.1016/j.immuni.2015.06.019
27. Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell (2011) 147:629-40. doi:10.1016/j.cell.2011.09.025
28. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A (1996) 93:6731-6. doi:10.1073/pnas.93.13.6731
29. Chiaro CR, Patel RD, Marcus CB, Perdew GH. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway. Mol Pharmacol (2007) 72:1369-79. doi:10.1124/mol.107.038968
30. Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, et al. Feedback control of AHR signalling regulates intestinal immunity. Nature (2017) 542:242-5. doi:10.1038/nature21080
31. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity (2013) 39:372-85. doi:10.1016/j.immuni.2013.08.003
32. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol (2009) 49:123-50. doi:10.1146/annurev.pharmtox.011008.145616
33. Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol (2011) 12:1055-62. doi:10.1038/ni.2104
34. Tait Wojno ED, Monticelli LA, Tran SK, Alenghat T, Osborne LC, Thome JJ, et al. The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol (2015) 8:1313-23. doi:10.1038/mi.2015.21
35. Xue L, Salimi M, Panse I, Mjösberg JM, McKenzie ANJ, Spits H, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol (2014) 133:1184-94. doi:10.1016/j.jaci.2013.10.056
36. Kuna P, Bjermer L, Tornling G. Two phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma. Drug Des Devel Ther (2016) 10:2759-70. doi:10.2147/DDDT.S105142
37. von Moltke J, O,Leary CE, Barrett NA, Kanaoka Y, Austen KF, Locksley RM. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med (2017) 214:27-37. doi:10.1084/jem.20161274
38. Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol (2013) 132:205-13. doi:10.1016/j.jaci.2013.03.048
39. Pelly VS, Kannan Y, Coomes SM, Entwistle LJ, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol (2016) 9:1-11. doi:10.1038/mi.2016.4
40. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med (2013) 5:174ra26. doi:10.1126/scitranslmed.3004812
41. Zhou W, Toki S, Zhang J, Goleniewksa K, Newcomb DC, Cephus JY, et al. Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses. Am J Respir Crit Care Med (2016) 193:31-42. doi:10.1164/rccm.201410-1793OC
42. Krishnamoorthy N, Burkett PR, Dalli J, Abdulnour R-E, Colas R, Ramon S, et al. Maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol (2015) 194:863-7. doi:10.4049/jimmunol.1402534
43. Duffin R, OConnor RA, Crittenden S, Forster T, Yu C, Zheng X, et al. Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis. Science (2016) 351:1333-8. doi:10.1126/science.aad9903
44. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature (2010) 463:540-4. doi:10.1038/nature08636
45. Molofsky AB, Nussbaum JC, Liang HE, Van Dyken SJ, Cheng LE, Mohapatra A, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med (2013) 210:535-49. doi:10.1084/jem.20121964
46. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science (2011) 332:243-7. doi:10.1126/science.1201475
47. Feuerer M, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 15:930-9. doi:10.1038/nm.2002
48. O,Sullivan TE, Rapp M, Fan X, Weizman OE, Bhardwaj P, Adams NM, et al. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity (2016) 45:1-14. doi:10.1016/j.immuni.2016.06.016
49. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 112:1796-808. doi:10.1172/JCI200319246
50. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell (2014) 157:1292-308. doi:10.1016/j.cell.2014.03.066
51. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature (2011) 480:104-8. doi:10.1038/nature10653
52. Fischer K, Ruiz HH, Jhun K, Finan B, Oberlin DJ, van der Heide V, et al. Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis. Nat Med (2017) 23:623-30. doi:10.1038/nm.4316
53. Pfeifer A, Hoffmann LS. Brown, beige, and white: the new color code of fat and its pharmacological implications. Annu Rev Pharmacol Toxicol (2015) 55:207-27. doi:10.1146/annurev-pharmtox-010814-124346
54. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 360:1509-17. doi:10.1056/NEJMoa0810780
55. Odegaard JI, Lee MW, Sogawa Y, Bertholet AM, Locksley RM, Weinberg DE, et al. Perinatal licensing of thermogenesis by IL-33 and ST2. Cell (2016) 166:841-54. doi:10.1016/j.cell.2016.06.040
56. Miller AM, Asquith DL, Hueber AJ, Anderson LA, Holmes WM, McKenzie AN, et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res (2010) 107:650-8. doi:10.1161/CIRCRESAHA.110.218867
57. Wang X, Ota N, Manzanillo P, Kates L, Zavala-Solorio J, Eidenschenk C, et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature (2014) 514:237-41. doi:10.1038/nature13564
58. Molofsky AB, Van Gool F, Liang HE, Van Dyken SJ, Nussbaum JC, Lee J, et al. Interleukin-33 and interferon-γ counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity (2015) 43:161-74. doi:10.1016/j.immuni.2015.05.019
59. Boulenouar S, Michelet X, Duquette D, Alvarez D, Hogan AE, Dold C, et al. Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity. Immunity (2017) 46:273-86. doi:10.1016/j.immuni.2017.01.008
60. MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol (2013) 31:259-83. doi:10.1146/annurev-immunol-032712-095956
61. Pearce E, Pearce E. Metabolic pathways in immune cell activation and quiescence. Immunity (2013) 38:633-43. doi:10.1016/j.immuni.2013.04.005
62. Buck MD, O,Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med (2015) 212:1345-60. doi:10.1084/jem.20151159
63. Keppel MP, Saucier N, Mah AY, Vogel TP, Cooper MA. Activation-specific metabolic requirements for NK cell IFN-γ production. J Immunol (2015) 194:1954-62. doi:10.4049/jimmunol.1402099
64. Marçais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol (2014) 15:749-57. doi:10.1038/ni.2936
65. Keating SE, Zaiatz-Bittencourt V, Loftus RM, Keane C, Brennan K, Finlay DK, et al. Metabolic reprogramming supports IFN- production by CD56bright NK cells. J Immunol (2016) 196:2552-60. doi:10.4049/jimmunol.1501783
66. Donnelly RP, Loftus RM, Keating SE, Liou KT, Biron CA, Gardiner CM, et al. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J Immunol (2014) 193:4477-84. doi:10.4049/jimmunol.1401558
67. Assmann N, O,Brien KL, Donnelly RP, Dyck L, Zaiatz-Bittencourt V, Loftus RM, et al. Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat Immunol (2017) 18:1197-206. doi:10.1038/ni.3838
68. O,Sullivan TE, Geary CD, Weizman OE, Geiger TL, Rapp M, Dorn GW II, et al. Atg5 is essential for the development and survival of innate lymphocytes. Cell Rep (2016) 15:1910-9. doi:10.1016/j.celrep.2016.04.082
69. O,Sullivan TE, Johnson LR, Kang HH, Sun JC. BNIP3- and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory. Immunity (2015) 43:331-42. doi:10.1016/j.immuni.2015.07.012
70. Robinette ML, Fuchs A, Cortez VS, Lee JS, Wang Y, Durum SK, et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol (2015) 16:306-17. doi:10.1038/ni.3094
71. Gury-BenAri M, Thaiss CA, Serafini N, Winter DR, Giladi A, Lara-Astiaso D, et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell (2016) 166:1231-46.e13. doi:10.1016/j.cell.2016.07.043
72. Xu CX, Wang C, Zhang ZM, Jaeger CD, Krager SL, Bottum KM, et al. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure. Int J Obes (Lond) (2015) 39:1300-9. doi:10.1038/ijo.2015.63